Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sylvie Scharl
Observed name:
Scharl, Sylvie
Institutions:
University of Zurich,
University Hospital Zurich
Observed institutions:
University of Zurich,
University Hospital Zurich,
Centre universitaire de médecine générale et santé publique, Lausanne,
University of Lausanne
ORCID:
0009-0009-4000-7200
Observed ORCID:
0009-0009-4000-7200
OpenAlex ID:
A5114042486
NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22
2016
·
Marianne R. Spalinger
, Stephanie Kasper
, et al.
·
Journal of Clinical Investigation
·
244
PDF
Pain in IBD Patients: Very Frequent and Frequently Insufficiently Taken into Account
2016
·
Jonas Zeitz
, Melike Ak
, et al.
·
PLoS ONE
·
177
PDF
Malignancies in Inflammatory Bowel Disease: Frequency, Incidence and Risk Factors—Results from the Swiss IBD Cohort Study
2018
·
Sylvie Scharl
, Christiane Barthel
, et al.
·
The American Journal of Gastroenterology
·
76
The Evolution of Health Care Utilisation and Costs for Inflammatory Bowel Disease Over Ten Years
2019
·
Nadia Pillai
, Mark Dusheiko
, et al.
·
Journal of Crohn s and Colitis
·
67
NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22
2016
·
Marianne R. Spalinger
, Stephanie Kasper
, et al.
·
Journal of Clinical Investigation
·
50
PDF
The Impact of Azathioprine-Associated Lymphopenia on the Onset of Opportunistic Infections in Patients with Inflammatory Bowel Disease
2016
·
Marius Vögelin
, Luc Biedermann
, et al.
·
PLoS ONE
·
44
PDF
Cohort Profile Update: The Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS)
2019
·
Valérie Pittet
, Pierre Michetti
, et al.
·
International Journal of Epidemiology
·
40
PDF
Malignancies in Patients with Inflammatory Bowel Disease: A Single-Centre Experience
2016
·
Mehdi Madanchi
, Jonas Zeitz
, et al.
·
Digestion
·
35
PDF
Patients’ views on fecal microbiota transplantation: an acceptable therapeutic option in inflammatory bowel disease?
2016
·
Jonas Zeitz
, Marina Bissig
, et al.
·
European Journal of Gastroenterology & Hepatology
·
32
Cytomegalovirus disease in inflammatory bowel disease: epidemiology and disease characteristics in a large single-centre experience
2016
·
Jonas Bontà
, Jonas Zeitz
, et al.
·
European Journal of Gastroenterology & Hepatology
·
27
Effects of anti-TNF therapy and immunomodulators on anxiety and depressive symptoms in patients with inflammatory bowel disease: a 5-year analysis
2021
·
Alexander R. Siebenhüner
, Jean-Benoît Rossel
, et al.
·
Therapeutic Advances in Gastroenterology
·
26
PDF
Patients’ perceptions on the impact of coffee consumption in inflammatory bowel disease: friend or foe? – a patient survey
2015
·
Christiane Barthel
, Sandra Wiegand
, et al.
·
Nutrition Journal
·
23
PDF
Evaluating the Cost-Effectiveness of Early Compared with Late or No Biologic Treatment to Manage Crohn’s Disease using Real-World Data
2019
·
Nadia Pillai
, Judith E Lupatsch
, et al.
·
Journal of Crohn s and Colitis
·
22
PDF
Risk Factors for the Development of Fistulae and Stenoses in Crohn Disease Patients in the Swiss Inflammatory Bowel Disease Cohort
2016
·
Jonas Zeitz
, Nicolas Fournier
, et al.
·
Inflammatory Intestinal Diseases
·
20
PDF
NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22
2023
·
Marianne R. Spalinger
, Stephanie Kasper
, et al.
·
Journal of Clinical Investigation
·
18
PDF
Efficacy and Safety of Anthocyanin-Rich Extract in Patients with Ulcerative Colitis: A Randomized Controlled Trial
2024
·
Luc Biedermann
, Michael Doulberis
, et al.
·
Nutrients
·
15
PDF
Differences in Outcomes Reported by Patients With Inflammatory Bowel Diseases vs Their Health Care Professionals
2018
·
Valérie E.H. Pittet
, Michel H. Maillard
, et al.
·
Clinical Gastroenterology and Hepatology
·
15
The Clinical Relevance of the IBD-Associated Variation within the Risk Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 2 in Patients of the Swiss IBD Cohort
2016
·
Marianne R. Spalinger
, Marius Voegelin
, et al.
·
Digestion
·
15
Association of IBD specific treatment and prevalence of pain in the Swiss IBD cohort study
2019
·
Lorenz Bon
, Sylvie Scharl
, et al.
·
PLoS ONE
·
12
PDF
Protocol for a prospective, controlled, observational study to evaluate the influence of hypoxia on healthy volunteers and patients with inflammatory bowel disease: the Altitude IBD Study
2017
·
Stephan Vavricka
, Pedro A Ruiz
, et al.
·
BMJ Open
·
11
PDF
Genotype-Phenotype Associations of the CD-Associated Single Nucleotide Polymorphism within the Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 22 in Patients of the Swiss IBD Cohort
2016
·
Marianne R. Spalinger
, Jonas Zeitz
, et al.
·
PLoS ONE
·
7
PDF
Crosstalk within peripheral blood mononuclear cells mediates anti-inflammatory effects of n-3 PUFA-rich lipid emulsions in parenteral nutrition
2023
·
Paulina Wawrzyniak
, Barbara Hubeli
, et al.
·
Clinical Nutrition
·
5
PDF
Blood-borne immune cells carry low biomass DNA remnants of microbes in patients with colorectal cancer or inflammatory bowel disease
2025
·
Yasser Morsy
, Åsa Walberg
, et al.
·
Gut Microbes
·
4
PDF
A Prospective Interventional Study to Evaluate the Effect of Hypoxia on Healthy Volunteers and Patients With Inflammatory Bowel Disease: The Altitude Inflammatory Bowel Disease Study
2025
·
Stephan R. Vavricka
, Jonas Zeitz
, et al.
·
The American Journal of Gastroenterology
NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22
2023
·
Spalinger, Marianne R
, Kasper, Stephanie
, et al.
·
Zurich Open Repository and Archive (University of Zurich)
Show more works
View as search
Works count:
39
Citation count:
984
H-index:
15
I10-index:
20
Year
Topic
Type